©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Faricimab in Phase 2 and 3

A Look at Visual Outcomes in GATHER2
A Look at Visual Outcomes in GATHER2

Carl Danzig, MD

OCS-01 (Oculis) in DME: A Phase 3 Update
OCS-01 (Oculis) in DME: A Phase 3 Update

Carl Danzig, MD

Faricimab in Phase 2 and 3

Carl Danzig, MD

ASRS Meeting Coverage Day 1: TALON and TRUCKEE in Wet AMD

Carl Regillo, MD; and Carl Danzig, MD